Poland· PL-100125260
Milgamma 100
A vitamin b1 in combination with vitamin b6 and/or vitamin b12 product containing benfothiaminum + pyridoxini hydrochloridum, registered in Poland by Woerwag Pharma GmbH & Co. KG. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Benfothiaminum + pyridoxini hydrochloridum is registered in 7 of 19 countries.
Countries holding a registration under ATC A11DB (vitamin b1 in combination with vitamin b6 and/or vitamin b12), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Benfothiaminum + pyridoxini hydrochloridum · ATC A11DB
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Icelandprice
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Benfothiaminum + Pyridoxini hydrochloridum
- Manufacturer
- Woerwag Pharma GmbH & Co. KG
- Country
- Poland (PL)
- ATC code
- A11DB
- ATC class
- Vitamin B1 in combination with vitamin B6 and/or vitamin B12
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 9
- gtin05909991080433
- gtin05909991080471
- gtin05909991428723
- gtin05909991080440
- gtin05909991080457
- gtin05909991080464
- gtin05909991080419
- gtin05909991080426
- gtin04030674022721
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Benfothiaminum + pyridoxini hydrochloridum in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Bulgaria · Бевит, Милгамма 100, Milgamma 100
- Czechia · Neurogamma
- Germany · Milgamma, Milgamma Na
- Estonia · Milgamma 100, Senvalan
- Hungary · Milgamma Neuro, Neurogerlon Mite
- Lithuania · Milgamma, Neurobixin
- Latvia · Milgamma, Senvalan
- Romania · Milgamma, Neuroduovit
- Slovenia · Milgamma, Neuroduovit
- Slovakia · Milgamma, Neuroduovit
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/192a989a-0f50-461e-8ef3-2ad94341219d GET /v1/drugs/192a989a-0f50-461e-8ef3-2ad94341219d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Drażetki",
"source": "urpl",
"strength": "100 mg + 100 mg",
"packaging": "05909991080419 ¦ Rp ¦ 23641\n30 draż. 200 mg (100 mg + 100 mg)\n05909991080426 ¦ Rp ¦ 23642\n60 draż. 200 mg (100 mg + 100 mg)\n05909991080433 ¦ Rp ¦ 23643\n100 draż. 200 mg 100 mg + 100 mg\n05909991080440 ¦ Rp ¦ 23644\n500 draż. 200 mg (100 mg + 100 mg)\n05909991080457 ¦ Rp ¦ 23645\n1000 draż. 200 mg (100 mg + 100 mg)\n05909991080464 ¦ Rp ¦ 23646\n5000 draż. 200 mg (100 mg + 100 mg)\n05909991080471 ¦ Rp ¦ 23647\n10000 draż. 200 mg (100 mg + 100 mg)\n05909991428723 ¦ Rp ¦ 136181\n15 draż. 200 mg (100 mg + 100 mg)\n04030674022721 ¦ Rp ¦ 165801\n90 draż. (100 mg + 100 mg)",
"substance": "Benfothiaminum 100 mg/1 tabl. + Pyridoxini hydrochloridum (Vitaminum B6) 100 mg",
"common_name": "Benfothiaminum + Pyridoxini hydrochloridum",
"pl_product_id": "100125260",
"pozwolenie_nr": "10804",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about benfothiaminum + pyridoxini hydrochloridum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.